RAPH — Raphael Pharmaceutical Balance Sheet
0.000.00%
- $7.85m
- $8.44m
Annual balance sheet for Raphael Pharmaceutical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2009 December 31st | 2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 0.105 | 0.153 | 0.288 | 0.23 | 0.019 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 0.557 | 0.422 | 0.331 | 0.237 | 0.025 |
| Net Property, Plant And Equipment | — | — | 0.002 | 0.002 | 0.002 |
| Net Intangible Assets | |||||
| Total Assets | 0.566 | 0.422 | 0.333 | 0.239 | 0.027 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.763 | 0.294 | 0.227 | 0.132 | 0.769 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 0.763 | 0.294 | 0.227 | 0.132 | 0.769 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -0.197 | 0.128 | 0.106 | 0.107 | -0.742 |
| Total Liabilities & Shareholders' Equity | 0.566 | 0.422 | 0.333 | 0.239 | 0.027 |
| Total Common Shares Outstanding |